![William M. Skea](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William M. Skea
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von William M. Skea
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Oxford GlycoSciences Plc
![]() Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK.
13
| Extinct | Pharmaceuticals: Major | 13 |
PerSeptive Biosystems, Inc.
![]() PerSeptive Biosystems, Inc. Medical SpecialtiesHealth Technology PerSeptive Biosystems developed and manufactured an integrated system for the purification, analysis, and synthesis of bio-molecules, reducing the time and cost of drug discoveries. BVP’s Chris Gabrieli invested in the company’s second round in December 1989. PerSeptive was purchased by Perkin Elmer, Inc. (NYSE: PKI) in 1998, it is a part of Applied Biosystems (NYSE: ABI), a subsidiary of Applera, Perkin Elmer’s former biotechnology division
5
| Extinct | Medical Specialties | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von William M. Skea
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CuraGen Corp.
![]() CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Director/Board Member | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
UNITED THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Biacore International AB
![]() Biacore International AB Pharmaceuticals: MajorHealth Technology Biacore International AB offers systems that generate data on the interactions between proteins and small molecule drug candidates. Its systems are used in pharmaceutical drug discovery, antibody characterization, proteomics, immunogenicity, biotherapeutic development and manufacture and life science research applications. The company serves research centers, pharmaceutical and biotechnology companies. Biacore International markets its products in the United States, Europe, Japan and Australia. The company was founded in 1984 and is headquartered in Uppsala, Sweden | Pharmaceuticals: Major | Chief Executive Officer | |
Advent Venture Partners LLP
![]() Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
VisEn Medical, Inc.
![]() VisEn Medical, Inc. Medical/Nursing ServicesHealth Services VisEn's in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomographic (FMTTM) Imaging Systems provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo. VisEn's FMT systems and agents are used by leading research institutions and pharmaceutical companies in applications including cancer research, inflammation, cardiovascular, skeletal and pulmonary disease. The company also works with large pharmaceutical partners to design ranges of tailored molecular imaging agents and applications that are designed to their specific pre-clinical and clinical research areas. | Medical/Nursing Services | Director/Board Member | |
ARGENT BIOPHARMA LIMITED | Pharmaceuticals: Other | Chairman | |
Oxford BioTherapeutics Ltd.
![]() Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
SARTORIUS AG | Pharmaceuticals: Major | Director/Board Member | |
University of Oxford | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Xention Pharma Ltd.
![]() Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Director/Board Member | |
University of Cambridge | College/University | Graduate Degree | |
Flagship Pioneering
![]() Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Pulmagen Therapeutics (Synergy) Ltd.
![]() Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
University of Uppsala | College/University | Undergraduate Degree | |
University of East Anglia | College/University | Undergraduate Degree | |
The Library of Congress (District of Columbia) | General Government | Corporate Officer/Principal | |
University of Surrey | College/University | Doctorate Degree | |
Bayes Business School | College/University | Masters Business Admin | |
AstraZeneca, Inc.
![]() AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Corporate Officer/Principal | |
Institute of Biology | President | ||
Sareum Ltd.
![]() Sareum Ltd. Drugstore ChainsRetail Trade Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK | Drugstore Chains | Director/Board Member | |
Celtic Pharma GP Ltd. | Director/Board Member | ||
Interpharma Investments Ltd.
![]() Interpharma Investments Ltd. Pharmaceuticals: MajorHealth Technology Interpharma Investments Ltd. operates as a holding company with interest in the distribution and manufacturing of pharmaceutical products. It provides product development, planning and procurement, and commercial manufacturing services. It also offers marketing services and support solutions to the pharmaceutical companies. The company is headquartered in Hong Kong. | Pharmaceuticals: Major | Director/Board Member | |
G.D. Searle LLC | Corporate Officer/Principal | ||
Galenica AB
![]() Galenica AB Pharmaceuticals: MajorHealth Technology Galenica AB develops and manufactures pharmaceutical drugs. It offers service to partners for the development of oral, dermal, nasal, rectal, pulmonary and parenteral formulations of small molecules to peptides/proteins and biologics. The company was founded in 1999 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
SYNLAB International GmbH
![]() SYNLAB International GmbH Medical/Nursing ServicesHealth Services SYNLAB International GmbH offers medical laboratory services for practicing doctors, clinics and the pharmaceutical industry. It offers medical instruments, transfusion medicines, cytology, pathology, human genetics, and general hygiene services. The company was founded by Bartl Wimmer in 1998 and is headquartered in Munich, Germany. | Medical/Nursing Services | Chairman | |
Kind Consumer Ltd.
![]() Kind Consumer Ltd. Pharmaceuticals: MajorHealth Technology Kind Consumer Ltd. operates as a healthcare research and development company which focuses on the inhalation technologies. It offers Voke, Oxette, Evo, and Polykind products. The company was founded by Alexander Thomas Hearn in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Soho Flordis International Pty Ltd.
![]() Soho Flordis International Pty Ltd. Pharmaceuticals: OtherHealth Technology Soho Flordis International Pty Ltd. manufactures natural medicine products. Its brands include flordis, ProThera, COMPLEMENTARY, ginsana and KLAIRE LABS. Its products include ginsana, keenmind, nuvexa and gincosan. The company was founded in 2010 and is headquartered in St. Leonards, Australia. | Pharmaceuticals: Other | Director/Board Member | |
BIODEXA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chairman | |
Liverpool Chirochem Ltd.
![]() Liverpool Chirochem Ltd. BiotechnologyHealth Technology Liverpool Chirochem Ltd. Produces and supply small organic molecules for biotech and pharmaceutical research and development. The firm offers building blocks, screening libraries and chemistry services. The company was founded by Jianjun Wu and Paul Colbon is headquartered in Liverpool, the United Kingdom. | Biotechnology | Chairman | |
Opterion Health AG
![]() Opterion Health AG Medical/Nursing ServicesHealth Services Opterion Health AG is a Swiss company that focuses on bringing innovation to dialysis care and fostering home dialysis to improve the quality of life for patients suffering from end-stage renal disease (ESRD). Opterion Health is based in Muttenz, CH. The private company aims to increase the survival rates of people with ESRD and reduce healthcare costs. The company was founded in 2012 by Guido Grentzmann, and the CEO is Bjorn Englund. | Medical/Nursing Services | Chairman | |
Actimed Therapeutics Ltd.
![]() Actimed Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Actimed Therapeutics Ltd. is a British clinical stage specialty pharmaceutical company that focuses on bringing innovation to the treatment of muscle wasting disorders. Actimed is based in Ascot, UK. Actimed's lead product, ACM-001 (S-pindolol), targets multiple biological pathways that drive cachexia and has generated promising proof of concept data in a phase II clinical trial in patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). The company is currently preparing for further clinical studies of cachexia in these two cancer types. The company was founded in 2017 by Stefan D. Anker and Andrew Justin Stewart Coats, two world-leading physicians in muscle wasting research, together with Yann Colardelle, a professional in communications and medical education. | Miscellaneous Commercial Services | Chairman | |
SYNLAB AG | Medical/Nursing Services | Chairman | |
Drishti Discoveries Ltd.
![]() Drishti Discoveries Ltd. BiotechnologyHealth Technology Drishti Discoveries Ltd. is a British company founded in 2019 that aims to develop a gene therapy that provides a long-term knockdown of target gene expression. Drishti Discoveries is based in Cambridge, UK. The company uses technology to achieve this goal. The company's website uses cookies to improve user experience while navigating through the website. The website also uses third-party cookies to analyze and understand how users interact with the website. Necessary cookies are used to ensure basic functionalities and security features of the website. Functional cookies are used to perform certain functionalities like sharing the content of the website on social media platforms, collect feedback, and other third-party features. | Biotechnology | Chairman | |
Sp2 Asset Management Ltd. | Director/Board Member | ||
Oxford Glycobiology Institute | College/University | Director/Board Member |
Statistik
International
Vereinigtes Königreich | 27 |
Vereinigte Staaten | 10 |
Deutschland | 6 |
Schweden | 4 |
Australien | 3 |
Sektoral
Health Technology | 26 |
Consumer Services | 8 |
Health Services | 5 |
Finance | 4 |
Commercial Services | 4 |
Operativ
Director/Board Member | 117 |
Corporate Officer/Principal | 45 |
Chairman | 34 |
Chief Executive Officer | 24 |
President | 19 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Raj Bhikhu Parekh | 50 |
Stephen Parker | 34 |
David Ebsworth | 26 |
Dale Pfost | 22 |
Erik Walldén | 22 |
Michael L. Kranda | 15 |
Brian Lundstrom | 15 |
Christopher Moyses | 11 |
Shaun C. Lonergan | 11 |
Jonathan Terrett | 9 |
Anastasia Rader | 8 |
Gordon Holt | 6 |
Raymond Dwek | 6 |
Alasdair Stamps | 5 |
John F. Smith | 5 |
- Börse
- Insiders
- William M. Skea
- Unternehmensverbindungen